Highlights and Quick Summary
- Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending May 31, 2022 was 27.13% (a 17.29% increase compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -29.03%
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 16.92% (a 18.74% increase from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was 14.25% (a -91.05% decrease from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was 159.18% (a 50.5% increase from previous year)
- Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending May 31, 2022 was 27.21% (a -9.06% decrease compared to previous quarter)
- Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth increased by 113.24% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
| 31 May '22 | 28 Feb '22 | 30 Nov '21 | 31 Aug '21 |
|---|---|---|---|
| 27.21% | 29.92% | 16.46% | 12.76% |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative (SG&A) Expenses Growth of Organigram Holdings Inc.
Most recent Selling, General and Administrative (SG&A) Expenses Growthof OGI including historical data for past 10 years.Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Organigram Holdings Inc.
Organigram Holdings Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 27.13% | 23.13% | – | – | – |
| 2021 | 20.98% | 38.23% | 38.73% | -18.49% | 16.92% |
| 2020 | 4.95% | -29.84% | -1.97% | 59.26% | 14.25% |
| 2019 | 98.63% | 42.54% | 2.01% | -37.21% | 159.18% |
| 2018 | – | – | – | -49.65% | 105.77% |
| 2017 | – | – | – | – | 87.46% |
| 2016 | – | – | – | – | -46.65% |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic